SCHEMBL50803

SCHEMBL50803

CCOC(=O)c1ccc2c(=O)c3cc(C)ccc3sc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA7 P43166 2/20 0.44
CA9 Q16790 2/20 0.44
CA14 Q9ULX7 2/20 0.44
HCRTR1 O43613 2/20 0.44
RAB9A P51151 6/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
KDM4E B2RXH2 5/20 0.44
NPC1 O15118 5/20 0.44
ALDH1A1 P00352 8/20 0.44
KMT2A Q03164 3/20 0.44
NOD2 Q9HC29 1/20 0.44
STAT1 P42224 1/20 0.44
MAPT P10636 3/20 0.43
MEN1 O00255 2/20 0.43
HPGD P15428 5/20 0.42
POLB P06746 3/20 0.42
HSD17B10 Q99714 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29590299 1.00 CA12 (0.44) CA12CA1CA2CA7CA9
SCHEMBL31544289 0.93 HCRTR1 (0.50) CA12CA1CA2CA7CA9
SCHEMBL85997 0.91 ALDH1A1 (0.41) CA12CA1CA2CA7CA9
SCHEMBL11244564 0.91 GABRP (0.48) CA12CA1CA2CA7CA9
SCHEMBL51151 0.89 ALDH1A1 (0.47) RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A
SCHEMBL29501106 0.89 ALDH1A1 (0.47) RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A
SCHEMBL4543672 0.88 ALDH1A1 (0.44) RAB9ASMN1; SMN2NPC1ALDH1A1KMT2A
SCHEMBL4536097 0.87 ALDH1A1 (0.46) RAB9ANPC1ALDH1A1KMT2AMAPT
SCHEMBL4543668 0.87 KDM4E (0.40) RAB9ASMN1; SMN2KDM4ENPC1ALDH1A1
SCHEMBL4541593 0.87 CMA1 (0.48) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 813 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11382868-B2 Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same ICURE PHARMACEUTICAL INC. (KR) 2022-07-12 US claimed
CN-107652222-B Oxime ester photoinitiators 巴斯夫欧洲公司 2021-09-10 CN claimed
US-10919909-B2 Photoinitiated reactions LINTFIELD LIMITED (GB) 2021-02-16 US claimed
US-20190211031-A1 PHOTOINITIATED REACTIONS LINTFIELD LIMITED (GB) 2019-07-11 US claimed
US-20190046463-A1 ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME ICURE PHARMACEUTICAL INC. (KR) 2019-02-14 US claimed
EP-3415141-A1 ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME Icure Pharmaceutical Inc. (KR) 2018-12-19 EP claimed
EP-0138754-A2 Photocurable compositions CIBA-GEIGY AG (CH) 1985-04-24 EP claimed
US-12637600-B2 Photocurable composition, cured product of same, photofusible resin composition and adhesive set RESONAC CORPORATION (JP) 2026-05-26 US disclosed
EP-4743828-A1 PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING BASF SE (DE) 2026-05-20 EP disclosed
US-20260132243-A1 THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTOMELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD RESONAC CORP (JP) 2026-05-14 US disclosed
EP-4555025-B1 PHOTOINITIATOR PACKAGE COMPRISING SPECIALISED BISACYLPHOSPHINE OXIDE PHOTOINITIATORS, FURTHER ACYLPHOSPHINE OXIDE PHOTOINITIATORS AND OPTICAL BRIGHTENER SENSITIZERS IGM GROUP B V (NL) 2026-05-13 EP disclosed
EP-3902878-B1 PHOTOINITIATORS IGM RESINS ITALIA SRL (IT) 2026-05-06 EP disclosed
EP-4410859-B1 THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTO-MELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD RESONAC CORP (JP) 2026-04-29 EP disclosed
US-4656292-A 2,3-dimethylmaleimido-alkyl haloacetates CIBA-GEIGY CORPORATION (US) 1987-04-07 US disclosed
EP-0088050-B1 COLOURED PHOTO-HARDENABLE COMPOSITION CIBA-GEIGY AG (CH) 1986-09-03 EP disclosed
US-4582862-A QUICK-SETTING PRINTING INKS BASED ON ACRYLATED RESINS CIBA-GEIGY CORPORATION (US) 1986-04-15 US disclosed
US-4544621-A Photocrosslinkable water-soluble polymers, containing maleimidyl and quaternary ammonium groups process for their preparation and use thereof CIBA GEIGY CORPORATION (US) 1985-10-01 US disclosed
EP-0138754-A2 Photocurable compositions CIBA-GEIGY AG (CH) 1985-04-24 EP disclosed
EP-0117233-A1 Coloured photo-curable mouldings CIBA-GEIGY AG (CH) 1984-08-29 EP disclosed
EP-0088050-A2 Coloured photo-hardenable composition CIBA-GEIGY AG (CH) 1983-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637600-B2 Photocurable composition, cured product of same, photofusible resin composition and adhesive set ESD, CDH1, ASH2L CA12 3779/4885CA1 3229/4885CA2 4345/4885
US-10919909-B2 Photoinitiated reactions KMO, DECR1, PPOX CA12 3096/4885CA1 2354/4885CA2 3961/4885
US-20190211031-A1 PHOTOINITIATED REACTIONS DOHH, PAH, DBH CA12 1824/4885CA1 1470/4885CA2 2519/4885
US-20260132243-A1 THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTOMELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD RER1, OXTR, MAP1LC3A CA12 2312/4885CA1 1713/4885CA2 4206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.